Also categorized in Information:
Late Effects of Treatment for Childhood Cancer (PDQ®)
x hide permanently

Alteration of Serum IgG Galactosylation as a Potential Biomarker for Diagnosis of Neuroblastoma.

ncbi.nlm.nih.gov

Alteration of Serum IgG Galactosylation as a Potential Biomarker for Diagnosis of Neuroblastoma.

J Cancer. 2018;9(5):906-913

Authors: Qin W, Pei H, Qin R, Zhao R, Han J, Zhang Z, Dong K, Ren S, Gu J

Abstract Background: Neuroblastoma (NB) is the most frequent pediatric malignant neoplasm that originates from embryonic neural crest cells.